FDA Clearance Process May Thwart 2010 Monograph Goal – ONP’s Ganley
This article was originally published in The Rose Sheet
Executive Summary
The Office of Nonprescription Products' goal of completing all OTC monographs by 2010 is viable only if FDA can improve its document-clearance process, according to ONP head Charles Ganley, MD